For best experience please turn on javascript and use a modern browser!
You are using a browser that is no longer supported by Microsoft. Please upgrade your browser. The site may not present itself correctly if you continue browsing.
Responsible Digital Transformations RDT

Synthetic data for responsible digital transformation to reduce animal testing and enhance new medical treatment uptake: an application in acute ischemic stroke

The uptake of new medical treatments in clinical practice is sub-optimal, resource-heavy, and time-consuming. In-silico/computational modelling can be valuable to refine, reduce, and even partially replace preclinical animal testing and subsequent clinical trials for development of new and personalized treatments.

In a large-scale EU-funded consortium, we have developed and validated an in-silico trial platform for treatment evaluation of patients with an acute ischemic stroke – the most debilitating disease in the world. This platform combines data- and knowledge-driven computational models of treatment with “synthetic patients” developed utilizing a large stroke database.

We believe that there is great value in the generalisation of synthetic patient generation tools to become relevant for wider populations and different diseases. With our collaboration between Amsterdam UMC, Informatics Institute, and the Faculty of Humanities, we aim to establish a dialogue between technical and social research to discuss the opportunities of the use of synthetic data and solutions to expand its applicability using artificial intelligence.

Project team:

  • Praneeta. R. Konduri (FdG)
  • Dr. Erik Bekkers (FNWI)
  • Dr. Randon Taylor (FGw)